tirzepatide pregnancy risks Inadvertent During Therapy... : Journal of Diabetology In patients with cardiometabolic #HFpEF,
Description
How Mounjaro works
The improvement in pharmacokinetics helped prevent the negative gastrointestinal side effects typical of GLP- 1-based selective agonists by reducing maximum drug exposure and reducing reliance on GLP- 1-mediated pharmacology
This titration is the single biggest reason side effects stay manageable and your prescriber adjusts the pace to you
The 5 mg pen is the first step-up from your starting dose
Metabolic rate improves
Danuglipron (Pfizer) is another oral GLP-1 currently in phase 2 trials, and CT-996 (Carmot Therapeutics) is in phase 1 trials
